$DTHR Dthera Sciences (DTHR), based in San Diego, Calif., is a digital therapeutics company focused on developing innovative quality of life therapies for the elderly and those suffering from cognitive decline. The Company's lead product, ReminX, is an artificial-intelligence-powered consumer health product designed to deliver reminiscence therapy digitally to individuals suffering from dementia from Alzheimer's disease and other neurodegenerative conditions, as well as for seniors experiencing social isolation. The company plans to launch ReminX commercially in the second quarter of 2018. For more information, please visit www.dthera.com and www.reminx.com
Contact:
Geno Kostikov
Director, Corporate Development
geno@dthera.com
(858) 215-6360
https://finance.yahoo.com/news/uipath-set-hos...00309.html
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!